These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6126381)

  • 1. Prenalterol is an agonist at beta 2- as well as at beta 1-adrenoceptors.
    Apperley GH; Drew GM; Sullivan AT
    Eur J Pharmacol; 1982 Jul; 81(4):659-63. PubMed ID: 6126381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrinsic sympathomimetic activity of the partial agonist prenalterol in relation to beta adrenoceptor interaction in various tissues, in vitro.
    Mattsson H; Hedberg A; Carlsson E
    J Pharmacol Exp Ther; 1983 Mar; 224(3):654-61. PubMed ID: 6131123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theoretical and practical problems with the assessment of intrinsic efficacy of agonists: efficacy of reputed beta-1 selective adrenoceptor agonists for beta-2 adrenoceptors.
    Kenakin TP
    J Pharmacol Exp Ther; 1982 Nov; 223(2):416-23. PubMed ID: 6127403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative efficacy of prenalterol and pirbuterol for beta-1 adrenoceptors: measurement of agonist affinity by alteration of receptor number.
    Kenakin TP; Beek D
    J Pharmacol Exp Ther; 1984 May; 229(2):340-5. PubMed ID: 6143816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta 1-Adrenoceptors mediating relaxation of the guinea-pig trachea: experiments with prenalterol, a beta 1-selective adrenoceptor agonist.
    Johansson U; Waldeck B
    J Pharm Pharmacol; 1981 Jun; 33(6):353-6. PubMed ID: 6115005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta 1- and beta 2-adrenoceptor antagonist activities of ICI-215001, a putative beta 3-adrenoceptor agonist.
    Tesfamariam B; Allen GT
    Br J Pharmacol; 1994 May; 112(1):55-8. PubMed ID: 7913381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta 1-and beta 2-adrenoceptor stimulatory effects of prenalterol.
    Mattsson H; Andersson T; Carlsson E; Hedberg A; Lundgren B; Olsson T
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(4):302-8. PubMed ID: 6132344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of in vivo treatment with isoprenaline or prenalterol on beta-adrenoceptor mechanisms in the heart and soleus muscle of the cat.
    Hedberg A; Mattsson H; Nerme V; Carlsson E
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):251-8. PubMed ID: 6145101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is prenalterol (H133/80) really a selective beta 1 adrenoceptor agonist? Tissue selectivity resulting from differences in stimulus-response relationships.
    Kenakin TP; Beek D
    J Pharmacol Exp Ther; 1980 May; 213(2):406-13. PubMed ID: 6102602
    [No Abstract]   [Full Text] [Related]  

  • 10. Prenalterol, a non-selective beta-adrenoceptor ligand with absolute beta1-selective partial agonist activity.
    Hedberg A; Mattsson H; Carlsson E
    J Pharm Pharmacol; 1980 Sep; 32(9):660-1. PubMed ID: 6107374
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta-adrenergic control of motility in the rat colon. I. Evidence for functional separation of the beta 1- and beta 2-adrenoceptor-mediated inhibition of colon activity.
    Ek BA; Bjellin LA; Lundgren BT
    Gastroenterology; 1986 Feb; 90(2):400-7. PubMed ID: 2867001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lack of a pronounced preference of prenalterol for the beta-l-adrenoceptor subtype.
    Rohm N; Wagner J; Schümann HJ
    Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(1):85-8. PubMed ID: 6113550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on mechanisms for beta-adrenoceptor mediated inhibition of colon motility.
    Ek B
    Acta Physiol Scand Suppl; 1985; 546():1-39. PubMed ID: 2869641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the beta-adrenergic inhibition of motility in cat colon strips.
    Ek B; Lundgren B
    Eur J Pharmacol; 1982 Jan; 77(1):25-31. PubMed ID: 6120845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiostimulatory effects of prenalterol, a beta-1 adrenoceptor partial agonist, in vivo and in vitro. Correlation between physiological effects and adenylate cyclase activity.
    Hedberg A; Carlsson E; Fellenius E; Lundgren B
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):185-91. PubMed ID: 6121296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic pharmacological properties of prenalterol.
    Mattsson H; Hedberg A; Carlsson E
    Acta Med Scand Suppl; 1982; 659():9-37. PubMed ID: 6127902
    [No Abstract]   [Full Text] [Related]  

  • 17. The measurement of the relative efficacy of agonists by selective potentiation of tissue responses: studies with isoprenaline and prenalterol in cardiac tissue.
    Kenakin TP; Beek D
    J Auton Pharmacol; 1984 Sep; 4(3):153-9. PubMed ID: 6208197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responses mediated via beta-1 adrenoceptors but not beta-2 adrenoceptors exhibit supersensitivity after chronic reserpine pretreatment.
    Grassby PF; Broadley KJ
    J Pharmacol Exp Ther; 1986 Jun; 237(3):950-8. PubMed ID: 3012076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta 1- and beta 2-adrenoceptor agonists have different effects on rat parotid acinar cells.
    Henriksson R
    Am J Physiol; 1982 May; 242(5):G481-5. PubMed ID: 6177253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of mechanical effects and beta-adrenoceptor binding of prenalterol in rat myocardium.
    Aass H; Hedberg A; Skomedal T; Carlsson E; Osnes JB
    Acta Pharmacol Toxicol (Copenh); 1983 Jul; 53(1):3-11. PubMed ID: 6310958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.